Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clindamycin: clinical and laboratory evaluation of parenteral therapy.

× No keyword cloud information.

16 in total

Review 1. Clindamycin--efficacy and toxicity.

Authors: R I Frankel
Journal: West J Med Date: 1975-06

2. Susceptibility of various serogroups of streptococci to clindamycin and lincomycin.

Authors: A W Karchmer; R C Moellering; B K Watson
Journal: Antimicrob Agents Chemother Date: 1975-02 Impact factor: 5.191

3. Parenteral clindamycin phosphate: pharmacology with normal and abnormal liver function and effect on nasal staphylococci.

Authors: D N Williams; K Crossley; C Hoffman; L D Sabath
Journal: Antimicrob Agents Chemother Date: 1975-02 Impact factor: 5.191

4. Subgaleal abscess: a preventable complication of scalp trauma.

Authors: S J Goodman; L Cahan; A W Chow
Journal: West J Med Date: 1977-08

Review 5. Interethnic differences in pharmacokinetics of antibacterials.

Authors: Danny Tsai; Janattul-Ain Jamal; Joshua S Davis; Jeffrey Lipman; Jason A Roberts
Journal: Clin Pharmacokinet Date: 2015-03 Impact factor: 6.447

6. Clindamycin phosphate in severe infections mainly caused by Bacteroides fragilis: clinical and microbiological evaluation.

Authors: E Schoutens; D Van Beers; E Yourassowsky
Journal: Infection Date: 1974 Impact factor: 3.553

Clindamycin: clinical and laboratory evaluation of parenteral therapy.

Review 1. Clindamycin--efficacy and toxicity.

2. Susceptibility of various serogroups of streptococci to clindamycin and lincomycin.

3. Parenteral clindamycin phosphate: pharmacology with normal and abnormal liver function and effect on nasal staphylococci.

4. Subgaleal abscess: a preventable complication of scalp trauma.

Review 5. Interethnic differences in pharmacokinetics of antibacterials.

6. Clindamycin phosphate in severe infections mainly caused by Bacteroides fragilis: clinical and microbiological evaluation.

7. Use of clindamycin in patients with liver disease.

8. Clindamycin for colonization and infection by methicillin-resistant Staphylococcus aureus.

9. Clindamycin therapy of experimental Staphylococcus aureus endocarditis.

10. In vitro comparison of clindamycin and pirlimycin (U-57930E) activity against Staphylococcus aureus.